Chemoinformaics analysis of Myricoside
Molecular Weight | 756.707 | nRot | 13 |
Heavy Atom Molecular Weight | 712.355 | nRig | 31 |
Exact Molecular Weight | 756.248 | nRing | 5 |
Solubility: LogS | -1.573 | nHRing | 3 |
Solubility: LogP | -0.682 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 97 | No. of Aliphatic Hetero Cycles | 3 |
No. of Heavy Atom | 53 | No. of Aromatic Carbocycles | 2 |
nHetero | 19 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 3 |
No. of Carbon atom | 34 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 19 | No. of Arom Bond | 12 |
nHA | 19 | APOL | 101.357 |
nHD | 11 | BPOL | 57.1611 |
QED | 0.057 |
Synth | 5.384 |
Natural Product Likeliness | 1.871 |
NR-PPAR-gamma | 0.957 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.002 |
Pgp-sub | 0.963 |
HIA | 0.999 |
CACO-2 | -6.561 |
MDCK | 0.0000799 |
BBB | 0.244 |
PPB | 0.873302 |
VDSS | 0.26 |
FU | 0.247211 |
CYP1A2-inh | 0.002 |
CYP1A2-sub | 0.015 |
CYP2c19-inh | 0.011 |
CYP2c19-sub | 0.05 |
CYP2c9-inh | 0.002 |
CYP2c9-sub | 0.129 |
CYP2d6-inh | 0.001 |
CYP2d6-sub | 0.148 |
CYP3a4-inh | 0.029 |
CYP3a4-sub | 0.019 |
CL | 0.44 |
T12 | 0.712 |
hERG | 0.021 |
Ames | 0.169 |
ROA | 0.081 |
SkinSen | 0.383 |
Carcinogencity | 0.063 |
EI | 0.003 |
Respiratory | 0.007 |
NR-Aromatase | 0.926 |
Antiviral | Yes |
Prediction | 0.661871 |